Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$486M |
| 2 |
American Tower
AMT
|
+$419M |
| 3 |
SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$409M |
| 4 |
US Bancorp
USB
|
+$358M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$333M |
Top Sells
| 1 |
Intel
INTC
|
+$590M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$497M |
| 3 |
Lockheed Martin
LMT
|
+$404M |
| 4 |
Lowe's Companies
LOW
|
+$383M |
| 5 |
RTN
Raytheon Company
RTN
|
+$373M |
Sector Composition
| 1 | Technology | 19.79% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Industrials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CFB
2551
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $1.32M | ﹤0.01% |
134,469
+5,721
| +4% | +$56K |
|
2552
Transmedics
TMDX
$3.91B
| $1.31M | ﹤0.01% |
72,923
+19,429
| +36% | +$348K |
|
|
STSA
2553
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $1.31M | ﹤0.01% |
45,445
+15,570
| +52% | +$448K |
|
2554
Atlanta Braves Holdings Series A
BATRA
$2.86B
| $1.31M | ﹤0.01% |
64,946
+5,849
| +10% | +$118K |
|
|
FPRX
2555
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.3M | ﹤0.01% |
213,626
-1,289
| -0.6% | -$7.87K |
|
2556
Arlo Technologies
ARLO
$1.82B
| $1.28M | ﹤0.01% |
496,139
+38,969
| +9% | +$101K |
|
2557
CEL-SCI Corp
CVM
$70.5M
| $1.27M | ﹤0.01% |
2,846
-47
| -2% | -$21K |
|
2558
Akero Therapeutics
AKRO
$3.48B
| $1.27M | ﹤0.01% |
50,945
+6,619
| +15% | +$165K |
|
2559
Greenlight Captial
GLRE
$426M
| $1.27M | ﹤0.01% |
194,153
+11,903
| +7% | +$77.6K |
|
2560
Novo Nordisk
NVO
$244B
| $1.26M | ﹤0.01% |
38,584
-82,886
| -68% | -$2.72M |
|
2561
Noodles & Co
NDLS
$30.7M
| $1.25M | ﹤0.01% |
206,805
+19,125
| +10% | +$116K |
|
|
TAST
2562
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $1.24M | ﹤0.01% |
255,400
+16,857
| +7% | +$81.6K |
|
2563
Co-Diagnostics
CODX
$13.1M
| $1.24M | ﹤0.01% |
+63,774
| New | +$1.24M |
|
2564
Carter Bankshares
CARE
$450M
| $1.23M | ﹤0.01% |
152,079
+12,639
| +9% | +$102K |
|
2565
Neurogene
NGNE
$271M
| $1.23M | ﹤0.01% |
3,698
+2,995
| +426% | +$995K |
|
2566
FuelCell Energy
FCEL
$222M
| $1.22M | ﹤0.01% |
17,945
+15,296
| +577% | +$1.04M |
|
|
ATHX
2567
DELISTED
Athersys, Inc. Common Stock
ATHX
| $1.22M | ﹤0.01% |
17,633
+4,356
| +33% | +$301K |
|
|
HTZ
2568
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $1.22M | ﹤0.01% |
862,227
-167,757
| -16% | -$237K |
|
2569
Acacia Research
ACTG
$317M
| $1.21M | ﹤0.01% |
295,382
+7,553
| +3% | +$30.9K |
|
2570
UNIFI
UFI
$82.8M
| $1.2M | ﹤0.01% |
93,463
+4,714
| +5% | +$60.7K |
|
2571
United States Lime & Minerals
USLM
$3.63B
| $1.2M | ﹤0.01% |
71,100
+3,440
| +5% | +$58.1K |
|
2572
WideOpenWest
WOW
$442M
| $1.2M | ﹤0.01% |
227,594
+70,350
| +45% | +$371K |
|
2573
Wave Life Sciences
WVE
$1.11B
| $1.2M | ﹤0.01% |
115,235
-6,226
| -5% | -$64.8K |
|
2574
Kiniksa Pharmaceuticals
KNSA
$2.75B
| $1.2M | ﹤0.01% |
47,047
+11,551
| +33% | +$294K |
|
|
LJPC
2575
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.19M | ﹤0.01% |
278,154
+143,700
| +107% | +$612K |
|